Helen C. Walkey

Helen C. Walkey

Auto-generated profile, based on publicly available information

Helen C. Walkey

Faculty of Medicine, Imperial College, London, UK

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2018 in BMJ Open
Verified
Journal Article
Open access
PDF file
VBVassiliki Bravis
Vassiliki Bravis
AKAkaal Kaur
Akaal Kaur
HWHelen C Walkey
Helen C Walkey
IGIan F Godsland
Ian F Godsland
SMShivani Misra
Shivani Misra
DJDesmond G Johnston
Desmond G Johnston
Objectives: To describe the characteristics of children and adults with incident type 1 diabetes in contemporary, multiethnic UK, focusing on differences between the islet autoantibody negative and positive. Design: Observational cohort study. Setting: 146 mainly secondary care centres across England and Wales. Participants: 3312 people aged ≥5 years were recruited within 6 months of a clinical diagnosis of type 1 diabetes via the National Institute for Health Research Clinical Research Network. 3021 were of white European ethnicity and 291 (9%) were non-white. There was a small male predominance (57%). Young people <17 years comprised 59%. Main outcome measures: Autoantibody status and characteristics at presentation. Results: The majority presented with classical osmotic symptoms, weight loss and fatigue. Ketoacidosis was common (42%), especially in adults, and irrespective of ethnicity. 35% were overweight or obese. Of the 1778 participants who donated a blood sample, 85% were positive for one or more autoantibodies against glutamate decarboxylase, islet antigen-2 and zinc transporter 8. Presenting symptoms were similar in the autoantibody-positive and autoantibody-negative participants, as was the frequency of ketoacidosis (43%vs40%, P=0.3). Autoantibody positivity was less common with increasing age (P=0.0001), in males compared with females (82%vs90%, P<0.0001) and in people of non-white compared with white ethnicity (73%vs86%, P<0.0001). Body mass index was higher in autoantibody-negative adults than autoantibody-positive adults (median, IQR 25.5, 23.1–29.2vs23.9, 21.4–26.7 kg/m2; P=0.0001). Autoantibody-negative participants were more likely to have a parent with diabetes (28%vs16%, P<0.0001) and less likely to have another autoimmune disease (4%vs8%, P=0.01). Conclusions: Most people assigned a diagnosis of type 1 diabetes presented with classical clinical features and islet autoantibodies. Although indistinguishable at an individual level, autoantibody-negative participants as a group demonstrated features more typically associated with other diabetes subtypes. Trial registration number: ISRCTN66496918; Pre-results.

1 December 2007 in Lighting Research & Technology
Verified
Journal Article
Closed access
TGT. Goodman
T. Goodman
AFA. Forbes
A. Forbes
HWH. Walkey
H. Walkey
MEM. Eloholma
M. Eloholma
LHL. Halonen
L. Halonen
ASA. Szalmas
A. Szalmas
The authors represent a research consortium1 which has adopted a task performance based approach for nighttime driving to establish a system for photometry in the mesopic region. This article analyses the experimental investigations described in earlier articles on visual performance in the mesopic domain using reaction time, detection threshold, and discrimination threshold techniques. These results are used to develop a system for mesopic photometry, which balances the quality of the fit to the experimental data with the ease of practical implementation by the lighting industry. A more complex model is also described, which takes account of the chromatic visual response channels and thus provides a better fit to some of the experimental results (particularly those involving monochromatic stimuli), but describes the totality of the data less well and is furthermore less suitable for practical photometric measurements.

1 June 2005 in Lighting Research & Technology
Verified
Journal Article
Closed access
MEM Eloholma
M Eloholma
MVM Viikari
M Viikari
LHL Halonen
L Halonen
HWH Walkey
H Walkey
TGT Goodman
T Goodman
GVG Várady
G Várady
At present, suitable methods to evaluate the visual effectiveness of lighting products in the mesopic region are not available. The majority of spectral luminous efficiency functions obtained to date in the mesopic range have been acquired by heterochromatic brightness matching. However, the most recent studies in the mesopic field have adopted a task performance-based approach. This paper summarizes the major mesopic models proposed so far, presenting in detail the experimental conditions of these studies. The authors represent a research consortium which has adopted the task performance-based approach for night-time driving in which mesopic visual performance has been divided into three subtasks. Data for each sub-task will be generated by using a set of common parameter values and 120 observers. The approach and methods used by the consortium are presented.

10 November 2022 in Diabetologia
Verified
Journal Article
Open access
PDF file
NTNicholas J. Thomas
Nicholas J. Thomas
HWHelen C. Walkey
Helen C. Walkey
AKAkaal Kaur
Akaal Kaur
SMShivani Misra
Shivani Misra
NONicholas Oliver
Nicholas Oliver
KPKashyap A. Patel
Kashyap A. Patel
Aims/hypothesis: The reason for the observed lower rate of islet autoantibody positivity in clinician-diagnosed adult-onset vs childhood-onset type 1 diabetes is not known. We aimed to explore this by assessing the genetic risk of type 1 diabetes in autoantibody-negative and -positive children and adults. Methods: We analysed GAD autoantibodies, insulinoma-2 antigen autoantibodies and zinc transporter-8 autoantibodies (ZnT8A) and measured type 1 diabetes genetic risk by genotyping 30 type 1 diabetes-associated variants at diagnosis in 1814 individuals with clinician-diagnosed type 1 diabetes (1112 adult-onset, 702 childhood-onset). We compared the overall type 1 diabetes genetic risk score (T1DGRS) and non-HLA and HLA (DR3-DQ2, DR4-DQ8 and DR15-DQ6) components with autoantibody status in those with adult-onset and childhood-onset diabetes. We also measured the T1DGRS in 1924 individuals with type 2 diabetes from the Wellcome Trust Case Control Consortium to represent non-autoimmune diabetes control participants. Results: The T1DGRS was similar in autoantibody-negative and autoantibody-positive clinician-diagnosed childhood-onset type 1 diabetes (mean [SD] 0.274 [0.034] vs 0.277 [0.026], p=0.4). In contrast, the T1DGRS in autoantibody-negative adult-onset type 1 diabetes was lower than that in autoantibody-positive adult-onset type 1 diabetes (mean [SD] 0.243 [0.036] vs 0.271 [0.026], p<0.0001) but higher than that in type 2 diabetes (mean [SD] 0.229 [0.034], p<0.0001). Autoantibody-negative adults were more likely to have the more protective HLA DR15-DQ6 genotype (15% vs 3%, p<0.0001), were less likely to have the high-risk HLA DR3-DQ2/DR4-DQ8 genotype (6% vs 19%, p<0.0001) and had a lower non-HLA T1DGRS (p<0.0001) than autoantibody-positive adults. In contrast to children, autoantibody-negative adults were more likely to be male (75% vs 59%), had a higher BMI (27 vs 24 kg/m2) and were less likely to have other autoimmune conditions (2% vs 10%) than autoantibody-positive adults (all p<0.0001). In both adults and children, type 1 diabetes genetic risk was unaffected by the number of autoantibodies (p>0.3). These findings, along with the identification of seven misclassified adults with monogenic diabetes among autoantibody-negative adults and the results of a sensitivity analysis with and without measurement of ZnT8A, suggest that the intermediate type 1 diabetes genetic risk in autoantibody-negative adults is more likely to be explained by the inclusion of misclassified non-autoimmune diabetes (estimated to represent 67% of all antibody-negative adults, 95% CI 61%, 73%) than by the presence of unmeasured autoantibodies or by a discrete form of diabetes. When these estimated individuals with non-autoimmune diabetes were adjusted for, the prevalence of autoantibody positivity in adult-onset type 1 diabetes was similar to that in children (93% vs 91%, p=0.4). Conclusions/interpretation: The inclusion of non-autoimmune diabetes is the most likely explanation for the observed lower rate of autoantibody positivity in clinician-diagnosed adult-onset type 1 diabetes. Our data support the utility of islet autoantibody measurement in clinician-suspected adult-onset type 1 diabetes in routine clinical practice. Graphical

1 December 2007 in Lighting Research & Technology
Verified
Journal Article
Closed access
PDF file
AFA. Freiding
A. Freiding
MEM. Eloholma
M. Eloholma
JKJ. Ketomäki
J. Ketomäki
LHL. Halonen
L. Halonen
HWH. Walkey
H. Walkey
PBP. Bodrogi
P. Bodrogi
Achromatic thresholds are measured at three sites to investigate the effects of light spectrum on achromatic detection thresholds in the mesopic region. The results of measurements using quasi-monochromatic targets reveal spectral sensitivity functions with two or three peaks, a so-called `chromatic effect' which is assumed to be due to the influence of the colour-opponent channels. This chromatic contribution seem to be less significant at lower luminances but it is accentuated for peripheral observation. Results obtained with broadband stimuli show that the contrast threshold, defined in terms of V(λ), is markedly higher for red targets than for other colours, particularly at lower light levels. For these broadband targets, contrast threshold values calculated using the new spectral sensitivity curves instead of V(λ) are in better agreement with the experimental results, particularly for the peripheral detection task.

1 December 2007 in Lighting Research & Technology
Verified
Journal Article
Closed access
PDF file
GVG. Várady
G. Várady
AFA. Freiding
A. Freiding
MEM. Eloholma
M. Eloholma
LHL. Halonen
L. Halonen
HWH. Walkey
H. Walkey
JAJ. Alferdinck
J. Alferdinck
The authors represent a research consortium which has adopted a task performance based approach for nighttime driving to obtain mesopic spectral sensitivity functions. This study describes investigations based on discrimination threshold techniques and compares the results with those obtained from detection threshold measurements. It forms a continuation of `Mesopic models — from brightness matching to visual performance in night-time driving: a review'. 1 The achromatic increment contrast threshold for discrimination of a quasi-static target represents the ability to correctly identify a target which has low contrast with the background and is therefore a highly relevant visual task in the context of nighttime driving. The psychophysical experiments reported here are carried out in the laboratory and in dynamic nighttime driving tests. The spectral sensitivity functions resulting from the discrimination threshold contrast investigations show a significant contribution from the colour-opponent (or chromatic) channels of the visual system. Similar features have been observed in results from investigations using detection threshold techniques.